详情页

资源类型：

文章类型：

作者：

Hu, Shaoxuan[1,2,7] * ; Song, Yuqin[3] ; Sun, Xiuhua[4] ; Su, Liping[5] ; Zhang, Wei[2,7] ; Jia, Jing[3] ; Bai, Ou[6] ; Yang, Sheng[1,2] ; Liang, Rong[8] ; Li, Xiaoling[9] ; Zhang, Huilai[10] ; Gao, Yuhuan[11]

; Zhang, Weijing[12] ; Xiao, Xiubin[12] ; Bao, Huizheng[13] ; Wang, Ningju[14] ; Ren, Hanyun[15] ; Cen, Xinan[15] ; Yang, Shun'e[16] ; Zhao, Yu[17] ; Wang, Yinan[18] ; Wang, Yalan[19] ; Liu, Aichun[20] ; Wang, Jingwen[21] ; Shi, Yuankai[1,2] ; Yuan, Ming[22] ; Li, Yufu[23] ; He, Xiaohui[1,2] ;

机构： [1]Chinese Acad Med Sci, Canc Hosp, Natl Clin Res Ctr Canc, Dept Med Oncol,Natl Canc Ctr, Beijing, Peoples R China [2]Peking Union Med Coll, Beijing, Peoples R China [3]Peking Univ Canc Hosp & Inst, Dept Lymphoma, Minist Educ, Key Lab Carcinogenesis & Translat Res, Beijing, Peoples R China [4]Dalian Med Univ, Hosp 2, Dept Med Oncol, Dalian, Peoples R China [5]Canc Hosp Shanxi Prov, Dept Hematol, Taiyuan, Shanxi, Peoples R China [6]Jilin Univ, Hosp 1, Dept Hematol, Jilin, Jilin, Peoples R China [7]Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Hematol, Beijing, Peoples R China [8]Fourth Mil Med Univ, Xijing Hosp, Dept Hematol, Xian, Shaanxi, Peoples R China [9]Liaoning Canc Hosp & Inst, Dept Med Oncol, Shenyang, Liaoning, Peoples R China [10]Tianjin Med Univ Canc Inst & Hosp, Natl Clin Res Ctr Canc, Key Lab Canc Prevent & Therapy, Dept Med Oncol, Tianjin, Peoples R China [11]Hebei Med Univ, Hosp 4, Dept Hematol, Shijiazhuang, Hebei, Peoples R China [12]Chinese Peoples Liberat Army, Hosp 307, Dept Med Oncol, Beijing, Peoples R China [13]Jilin Canc Hosp, Dept Med Oncol, Changchun, Jilin, Peoples R China [14]Ningxia Med Univ, Gen Hosp, Dept Med Oncol, Yinchuan, Peoples R China [15]Peking Univ, Hosp 1, Dept Hematol, Beijing, Peoples R China [16]Xinjiang Canc Hosp, Dept Med Oncol, Urumqi, Peoples R China [17]Chinese Peoples Liberat Army, Gen Hosp, Dept Hematol, Beijing, Peoples R China [18]Peoples Hosp Tangshan City, Dept Med Oncol, Tangshan, Peoples R China [19]Baotou Canc Hosp, Dept Med Oncol, Baotou, Peoples R China [20]Harbin Med Univ, Hosp 3, Dept Hematol, Haerbin, Peoples R China [21]Capital Med Univ, Beijing Tongren Hosp, Dept Hematol, Beijing, Peoples R China [22]IIT, Chicago, IL 60616 USA [23]Zhengzhou Univ, Affiliated Canc Hosp, Dept Hematol, Zhengzhou, Henan, Peoples R China

出处：

DOI：

ISSN：

语种：

WOS：

中科院分区：

出版当年[2019]版：

大类 | 2 区医学

小类 | 3 区肿瘤学

最新[2025]版：

大类 | 2 区医学

小类 | 3 区肿瘤学

JCR分区：

出版当年[2019]版：

Q2 ONCOLOGY

最新[2024]版：

Q2 ONCOLOGY

第一作者：

第一作者机构： [1]Chinese Acad Med Sci, Canc Hosp, Natl Clin Res Ctr Canc, Dept Med Oncol,Natl Canc Ctr, Beijing, Peoples R China [2]Peking Union Med Coll, Beijing, Peoples R China [7]Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Hematol, Beijing, Peoples R China

推荐引用方式(GB/T 7714)：

APA：

MLA：

Primary breast diffuse large B-cell lymphoma in the rituximab era: therapeutic strategies and patterns of failure (vol 109, pg 3943, 2018)

文献详情